TIL Insider Trading Activity and SEC Form 4 Filings
TIL insider trading summary
No open-market insider purchases or sales of Instil Bio, Inc. (TIL) have been reported on SEC Form 4 in the past 12 months.
Latest TIL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 10, 2025 | Sandeep Laumas | CFO and CBO | Sell | $404K (17,539 @ $23.04) |
| Sep 10, 2025 | Sandeep Laumas | CFO and CBO | Sell | $298K (12,461 @ $23.88) |
| Mar 23, 2021 | Nimish P Shah | Director | Buy | $2.1M (104,640 @ $20.00) |
| Mar 23, 2021 | Nimish P Shah | Director | Buy | $968K (48,390 @ $20.00) |
| Mar 23, 2021 | Nimish P Shah | Director | Buy | $392K (19,620 @ $20.00) |
| Mar 23, 2021 | Nimish P Shah | Director | Buy | $209K (10,470 @ $20.00) |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Buy | $6.0M (300,000 @ $20.00) |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Buy | $9.0M (450,000 @ $20.00) |
| Mar 23, 2021 | Vivo Capital IX, LLC | 10% Owner | Buy | $6.0M (300,000 @ $20.00) |
| Mar 23, 2021 | Nimish P Shah | Director | Buy | $2.3M (116,880 @ $20.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.